Literature DB >> 10952241

Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1.

A K Kiemer1, A M Vollmar, M Bilzer, T Gerwig, A L Gerbes.   

Abstract

BACKGROUND/AIMS: The cardiovascular hormone Atrial Natriuretic Peptide (ANP) attenuates activation of the pro-inflammatory transcription factor NF-kappaB in macrophages. ANP was also shown to protect from ischemia-reperfusion injury of the rat liver. This study aimed to investigate the effects of this immunomodulatory hormone and its second messenger cGMP on the activation of the two redox-sensitive transcription factors AP-1 and NF-kappaB and the expression of corresponding pro-inflammatory target genes during ischemia and reperfusion of the liver. The identification of the mechanisms underlying the protection by ANP should reveal new aspects concerning the pathomechanisms of ischemia/reperfusion injury.
METHODS: Rat livers were perfused with and without ANP or 8-Br-cGMP preceding 24 h of cold storage in University of Wisconsin solution. During reperfusion NF-kappaB and AP-1 DNA binding activities were determined in freeze-clamped liver samples by electrophoretic mobility shift assay. Protein levels of p50, p65, and of IkappaB were determined by Western blot. mRNA coding for inducible nitric oxide synthase, cyclooxygenase-2, and TNF-alpha was determined by RT-PCR and Northern blot.
RESULTS: After 45 min of reperfusion DNA binding activities of NF-kappaB were increased, whereas in ANP pre-treated livers this effect was markedly reduced. AP-1, another important redox-sensitive transcription factor, was activated and in the course of reperfusion the subunit composition of AP-1 changed as assessed by supershift assays. ANP markedly reduced binding activities of both forms of AP-1. 8-Br-cGMP mimicked the effects of ANP on NF-kappaB and AP-1. Neither inducible nitric oxide synthase nor cyclooxygenase-2 mRNA could be detected. In contrast, a profound expression of transcripts coding for TNF-alpha was detected in the course of reperfusion and ANP markedly reduced TNF-alpha mRNA expression.
CONCLUSION: ANP seems to mediate its protective effect during ischemia and reperfusion by reducing the activation of NF-kappaB and AP-1 via cGMP. The reduced binding activity of these redox-sensitive transcription factors was accompanied by a diminished mRNA expression of TNF-alpha, a cytokine known to be involved in cellular damage in ischemia reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952241     DOI: 10.1016/s0168-8278(00)80364-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Effect of atrial natriuretic peptide on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model.

Authors:  Katsumi Kobayashi; Kiyohiro Oshima; Masato Muraoka; Takahiko Akao; Osamu Totsuka; Hisashi Shimizu; Hiroaki Sato; Kazumi Tanaka; Kenjiro Konno; Koshi Matsumoto; Izumi Takeyoshi
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

3.  Passive heat therapy protects against endothelial cell hypoxia-reoxygenation via effects of elevations in temperature and circulating factors.

Authors:  Vienna E Brunt; Karen Wiedenfeld-Needham; Lindan N Comrada; Christopher T Minson
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

4.  V-PYRRO/NO downregulates mRNA expression levels of leukotriene C4 synthase during hepatic ischemia reperfusion injury in rats via inhibition of the nuclear factor-κB activation pathway.

Authors:  Feng-Fang Hong; Yi-Fan Wang; Hui Liu; Mei-Wen Yang; Shu-Long Yang
Journal:  Biomed Rep       Date:  2015-10-16

5.  Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy.

Authors:  Ana Agusti; Vicente Hernández-Rabaza; Tiziano Balzano; Lucas Taoro-Gonzalez; Andrea Ibañez-Grau; Andrea Cabrera-Pastor; Santos Fustero; Marta Llansola; Carmina Montoliu; Vicente Felipo
Journal:  CNS Neurosci Ther       Date:  2017-03-11       Impact factor: 5.243

6.  Murine guanylate cyclase C regulates colonic injury and inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Monica P Garin-Laflam; Elizabeth A Mann; Lucas D Bezerra; Simon P Hogan; Mitchell B Cohen
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

7.  Stimulation of p38 MAPK by hormonal preconditioning with atrial natriuretic peptide.

Authors:  Alexandra K Kiemer; Stefanie Kulhanek-Heinze; Tobias Gerwig; Alexander L Gerbes; Angelika M Vollmar
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 8.  Role of ischemic preconditioning in liver surgery and hepatic transplantation.

Authors:  Eduardo E Montalvo-Jave; Enrique Piña; Cesar Montalvo-Arenas; Raúl Urrutia; Luis Benavente-Chenhalls; Julieta Peña-Sanchez; David A Geller
Journal:  J Gastrointest Surg       Date:  2009-04-30       Impact factor: 3.452

9.  Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits.

Authors:  Takashige Yamada; Yoshifumi Kotake; Hiromasa Nagata; Junzo Takeda
Journal:  J Anesth       Date:  2013-06-05       Impact factor: 2.078

Review 10.  The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.

Authors:  Angelino Calderone
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.